Cargando…

Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance

Small cell lung cancer (SCLC) represents 15% of lung cancers and is characterized by early dissemination, development of chemoresistance and a poor prognosis. A host of diverse drugs failed invariably and its mechanisms of global chemoresistance have not been characterized so far. SCLC represents th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klameth, Lukas, Rath, Barbara, Hochmaier, Maximilian, Moser, Doris, Redl, Marlene, Mungenast, Felicitas, Gelles, Katharina, Ulsperger, Ernst, Zeillinger, Robert, Hamilton, Gerhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509650/ https://www.ncbi.nlm.nih.gov/pubmed/28706293 http://dx.doi.org/10.1038/s41598-017-05562-z

Ejemplares similares

Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines
por: Rath, Barbara, et al.
Publicado: (2019)

Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines
por: Hochmair, Maximilian, et al.
Publicado: (2019)

Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells
por: STICKLER, SANDRA, et al.
Publicado: (2023)

Small cell lung cancer: circulating tumor cell lines and expression of mediators of angiogenesis and coagulation
por: Rath, Barbara, et al.
Publicado: (2023)

Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancer
por: Hamilton, Gerhard, et al.
Publicado: (2015)

How to target small cell lung cancer
por: Hamilton, Gerhard, et al.
Publicado: (2015)

In vitro Cytotoxic Activities of the Oral Platinum(IV) Prodrug Oxoplatin and HSP90 Inhibitor Ganetespib against a Panel of Gastric Cancer Cell Lines
por: Klameth, Lukas, et al.
Publicado: (2017)

Synergism of Cyclin-Dependent Kinase Inhibitors with Camptothecin Derivatives in Small Cell Lung Cancer Cell Lines
por: Hamilton, Gerhard, et al.
Publicado: (2014)

In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer Agent
por: Olszewski, Ulrike, et al.
Publicado: (2009)

Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres
por: Breznik, Barbara, et al.
Publicado: (2022)

The Sulfatase Pathway for Estrogen Formation: Targets for the Treatment and Diagnosis of Hormone-Associated Tumors
por: Secky, Lena, et al.
Publicado: (2013)

Comparison of the effects of the oral anticancer platinum(IV) complexes oxoplatin and metabolite cis-diammine-tetrachlorido-platinum(IV) on global gene expression of NCI-H526 cells
por: Olszewski, Ulrike, et al.
Publicado: (2011)

Tumorigenic lung tumorospheres exhibit stem-like features with significantly increased expression of CD133 and ABCG2
por: Zhao, Wensi, et al.
Publicado: (2016)

Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer
por: Plangger, Adelina, et al.
Publicado: (2021)

Molecular Characterization of Circulating Tumor Cells Enriched by A Microfluidic Platform in Patients with Small-Cell Lung Cancer
por: Obermayr, Eva, et al.
Publicado: (2019)

Anticancer Activity of Fascaplysin against Lung Cancer Cell and Small Cell Lung Cancer Circulating Tumor Cell Lines
por: Rath, Barbara, et al.
Publicado: (2018)

Role of circulating tumor cell spheroids in drug resistance
por: Hamilton, Gerhard, et al.
Publicado: (2019)

Bevacizumab as adjunct to chemotherapy for chemoresistant ovarian cancer
por: Hamilton, Gerhard
Publicado: (2020)

In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds
por: Olszewski, Ulrike, et al.
Publicado: (2010)

Estrogen Biosynthesis and Action in Ovarian Cancer
por: Mungenast, Felicitas, et al.
Publicado: (2014)

Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer
por: Mungenast, Felicitas, et al.
Publicado: (2017)

Effects of metformin on human bone-derived mesenchymal stromal cell—breast cancer cell line interactions
por: Teufelsbauer, Maryana, et al.
Publicado: (2022)

Significance of circulating tumor cells in lung cancer: a narrative review
por: Hamilton, Gerhard, et al.
Publicado: (2023)

Cytotoxicity of combinations of the pan-KRAS SOS1 inhibitor BAY-293 against pancreatic cancer cell lines
por: Plangger, Adelina, et al.
Publicado: (2022)

The Role of Circulating Tumor Cells in Chemoresistant Metastatic Breast Cancer
por: Lisencu, Lorena Alexandra, et al.
Publicado: (2021)

Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer
por: Obermayr, Eva, et al.
Publicado: (2021)

Cytotoxicity of combinations of the pan-KRAS inhibitor BAY-293 against primary non-small lung cancer cells
por: Plangger, Adelina, et al.
Publicado: (2021)

Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian Cancer
por: Svoboda, Martin, et al.
Publicado: (2018)

Comparison of microfluidic platforms for the enrichment of circulating tumor cells in breast cancer patients
por: Sajdik, Constantin, et al.
Publicado: (2022)

Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities
por: Marfels, Christian, et al.
Publicado: (2013)

Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast Cancer
por: Welsch, Eva, et al.
Publicado: (2023)

Future Aspects for Cannabinoids in Breast Cancer Therapy
por: Kisková, Terézia, et al.
Publicado: (2019)

Interplay between Partial EMT and Cisplatin Resistance as the Drivers for Recurrence in HNSCC
por: Ingruber, Julia, et al.
Publicado: (2022)

Non-small cell lung cancer-small cell lung cancer transformation as mechanism of resistance to tyrosine kinase inhibitors in lung cancer
por: Rath, Barbara, et al.
Publicado: (2020)

Chemoresistance of Human Monocyte-Derived Dendritic Cells Is Regulated by IL-17A
por: Olsson Åkefeldt, Selma, et al.
Publicado: (2013)

Mechanisms of chemoresistance in cancer stem cells
por: Abdullah, Lissa Nurrul, et al.
Publicado: (2013)

Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
por: Chen, Xun, et al.
Publicado: (2020)

Integrin Signaling in Cancer Cell Survival and Chemoresistance
por: Aoudjit, Fawzi, et al.
Publicado: (2012)

Procathepsin D Involvement in Chemoresistance of Cancer Cells
por: Vetvicka, Vaclav, et al.
Publicado: (2012)

Targeting Cancer Stem Cells to Overcome Chemoresistance
por: Nunes, Toni, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gp16l11a94gi6e0ikvrsv9e2ge